|
1
|
Capture and visualization of hydrogen sulfide by a fluorescent probe.
|
Angew Chem Int Ed Engl
|
2011
|
1.57
|
|
2
|
Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen.
|
Prostate
|
2008
|
1.36
|
|
3
|
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer.
|
J Nucl Med
|
2009
|
1.31
|
|
4
|
Probing for a hydrophobic a binding register in prostate-specific membrane antigen with phenylalkylphosphonamidates.
|
Bioorg Med Chem
|
2004
|
1.23
|
|
5
|
Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8/-3 cascade pathway.
|
Int J Oncol
|
2010
|
1.09
|
|
6
|
Substrate specificity of prostate-specific membrane antigen.
|
Bioorg Med Chem
|
2007
|
1.09
|
|
7
|
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells.
|
Int J Oncol
|
2012
|
1.06
|
|
8
|
Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.
|
Cancer Lett
|
2010
|
1.06
|
|
9
|
A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.
|
Bioorg Med Chem Lett
|
2010
|
1.01
|
|
10
|
In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen.
|
Prostate
|
2009
|
0.93
|
|
11
|
Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium.
|
Int J Oncol
|
2011
|
0.89
|
|
12
|
Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.
|
Bioorg Med Chem Lett
|
2012
|
0.81
|